FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $180 thousand.
The third quarter was important for Adverum, as we reported sustained benefits from a single... More

